Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeSince 1981 I have demonstrated clinically that mitochondrial impirment represents the conditio sine qua non of oncogenesis.
Posted by Stagnaro on 07 Oct 2015 at 15:13 GMT
I consider really fascinating this paper publish on PLoS Genetics June 30, 2015, DOI: 10.1371/journal.pgen.1005333
at URL http://journals.plos.org/...
As a matter of facts, one may understand my 34-year-old clinical discovery on the relation between mitochondrial inherited disorder, I have termed Congenital Acydosic Enzyme-Metabolic Histangiopathy, CAEMH, and malignancy occurrence (1). At the begin of 1980 I have discovered with a common stethoscope such a mitochondrial maternally heritable impairment, emphasising that it is the conditio sine qua non of the most severe disorders, including cancer, both solid and liquid.
Now, Prof Claes M. Gustafsson, in an outstanding manner, explains clearly the importance of the scientific discoveries of the three Nobel Prizes for chemistry 2015, related to the precise mechanisms of n-DNA repair. Therefore, I am very happy and delighted with these scientific advances, corroborating my old discoveries and especially Quantum Therapy (2-5)
http://www.nobelprize.org...
References
1)Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica. X Congr. Naz. Soc. It. di Microangiologia e Microcircolazione. Atti, 61. 6-7 Novembre, 1981 Siena
2)Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica condizione necessaria non sufficiente della oncogenesi. XI Congr. Naz. Soc. It. di Microangiologia e Microcircolaz. Abstracts, pg 38, 28 Settembre-1 Ottobre, 1983, Bellagio (Italy).
3) Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica. Gazz Med. It. – Asch. Sci, Med. 144, 423, 1985.
4) Sergio Stagnaro and Simone Caramel. BRCA-1 and BRCA-2 mutation bedside detection and breast cancer clinical primary prevention. Front. Genet. | doi: 10.3389/fgene.2013.00039. http://www.frontiersin.or... [MEDLINE]
5) Sergio Stagnaro and Simone Caramel. The Role of Modified Mediterranean Diet and Quantum Therapy in Oncological Primary Prevention. Bentham PG.,Current Nutrition & Food Science ISSN (Print): 1573-4013; ISSN (Online): 2212-3881. VOLUME: 9, ISSUE: 1; DOI: 10.2174/1573401311309010011;
http://www.eurekaselect.c...